This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

€500 savings end in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
THE SPRINGTIME PARTNERING EVENT
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

Bantam Pharmaceutical

Profile

Bantam Pharmaceutical is developing small molecule cancer therapeutics for hematological malignancies and select solid tumors. FDA recently cleared our Phase 1 protocol for a first in humans study that we intend to initiate in 2023. We are seeking biopharma partners or investors to join our current investors in bringing this important novel treatment option to the clinic.